One more South Africa-based group, drove by virologist Alex Sigal at the Africa Health Research Institute in Durban, is directing comparative trial of infection killing antibodies utilizing irresistible SARS-CoV-2 particles. So is a group driven by Pei-Yong Shi, a virologist at the University of Texas Medical Branch in Galveston, who is working together with the producers of the Pfizer-BioNTech antibody to decide how it holds facing Omicron. "I was actually quite concerned when I saw the star grouping of ch